<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=utf-8">
<META content="MSHTML 6.00.2900.3603" name=GENERATOR>
<STYLE></STYLE>
</HEAD>
<BODY bgColor=#ffffff>
<DIV><FONT face=Arial size=2>Dear all</FONT></DIV>
<DIV><FONT face=Arial size=2></FONT> </DIV>
<DIV><FONT face=Arial size=2>We have a 42 years old patients with VL here in
Nepal treated initially with Amphotoricin B in another center incompletely.
This patients also received Meltefosine for 28 days few months back. He was
referred to our hospital 2 months ago with fever and spleenomegaly. Bone
marrow aspiration showed positive for LD bodies. We treated the patients with
Lipid complex ambhotoricin 5 mg/kg alternate daily for five days. The spleen
size reduced and patients was discharged and asked him to come hospital
after month. During his hospital visit we performed Bone marrow aspiration
showed planty of LD bodies. Since we have no other choice we started Ambhotoricn
B 1mg/kg daily for 21 days. The spleen size almost not palpable and on 22 days
after the treatment we performed bone marrow which shows scanty LD
bodies. </FONT></DIV>
<DIV><FONT face=Arial size=2>Anyone can suggest for the furthere
plan.</FONT></DIV>
<DIV><FONT face=Arial size=2></FONT> </DIV>
<DIV><FONT face=Arial size=2>Thanks,</FONT></DIV>
<DIV><FONT face=Arial size=2></FONT> </DIV>
<DIV><FONT face=Arial size=2>Dr. Basu Dev Pandey, MD, PhD<BR>Sukra Raj
Infectious and Tropical Disease Hospital<BR>Teku, Kathmandu, Nepal<BR>Tel:
977-1-4253395<BR>Email: <A
href="mailto:basupandey@wlink.com.np">basupandey@wlink.com.np</A></FONT></DIV>
<BLOCKQUOTE
style="PADDING-RIGHT: 0px; PADDING-LEFT: 5px; MARGIN-LEFT: 5px; BORDER-LEFT: #000000 2px solid; MARGIN-RIGHT: 0px">
<DIV style="FONT: 10pt arial">----- Original Message ----- </DIV>
<DIV
style="BACKGROUND: #e4e4e4; FONT: 10pt arial; font-color: black"><B>From:</B>
<A title=sinval@cpqam.fiocruz.br href="mailto:sinval@cpqam.fiocruz.br">Sinval
Pinto Brandão Filho</A> </DIV>
<DIV style="FONT: 10pt arial"><B>To:</B> <A title=leish-l@lineu.icb.usp.br
href="mailto:leish-l@lineu.icb.usp.br">leish-l@lineu.icb.usp.br</A> </DIV>
<DIV style="FONT: 10pt arial"><B>Sent:</B> Sunday, April 18, 2010 1:52
AM</DIV>
<DIV style="FONT: 10pt arial"><B>Subject:</B> Re: [Leish-l] name</DIV>
<DIV><BR></DIV>
<P><SPAN style="COLOR: #1f497d">There is a consensus in the different
opinions, perfectly explained in the messages of professors Killick, Ashford
and Bryceson: anthroponotic visceral leishmaniasis and zoonotic visceral
leishmaniasis. The name calazar used in Brazil is only an neologism derived
of kala-azar to the common name for the clinical form of the disease
visceral leishmaniasis, also used </SPAN><SPAN style="COLOR: #1f497d">in
the classical book “Calazar Canino” of professor Joaquim Alencar for the
disease form in dogs. </SPAN></P>
<DIV class=ecxSection1>
<P class=ecxMsoNormal><SPAN style="COLOR: #1f497d">According the WHO technical
report, leishmani<STRONG>a</STRONG>sis, not
leishmani<STRONG>o</STRONG>sis.</SPAN></P>
<P class=ecxMsoNormal><SPAN style="COLOR: #1f497d">Sinval</SPAN></P>
<P class=ecxMsoNormal><SPAN
style="COLOR: #1f497d"> </SPAN></P>
<DIV
style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0cm; BORDER-TOP: #b5c4df 1pt solid; PADDING-LEFT: 0cm; PADDING-BOTTOM: 0cm; BORDER-LEFT: medium none; PADDING-TOP: 3pt; BORDER-BOTTOM: medium none">
<P class=ecxMsoNormal><STRONG><SPAN
style="FONT-SIZE: 10pt">De:</SPAN></STRONG><SPAN style="FONT-SIZE: 10pt">
leish-l-bounces@lineu.icb.usp.br [mailto:leish-l-bounces@lineu.icb.usp.br]
<STRONG>Em nome de </STRONG>Carlos Costa<BR><STRONG>Enviada em:</STRONG>
quinta-feira, 8 de abril de 2010 08:14<BR><STRONG>Para:</STRONG> Christopher
Peacock<BR><STRONG>Cc:</STRONG> Leish-L<BR><STRONG>Assunto:</STRONG> Re:
[Leish-l] name</SPAN></P></DIV>
<P class=ecxMsoNormal> </P>
<DIV>
<P class=ecxMsoNormal><SPAN>Dear,</SPAN></P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN></SPAN> </P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN>Now, urban kala-azar is endemic in many Brazilian
state capitals, and everybody, doctors and the media, calls it as
<EM>"calazar"</EM>. However, in most Brazilian scientific papers,
"visceral leishmaniasis" ("<EM>leishmaniose visceral"</EM>, in Portuguese) is
preferred, specially when the text is written in
English.</SPAN></P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN></SPAN> </P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN>Another point is that if one says just
"leishmaniose" in Brazil it will be generally understood as cutaneous
leishmaniasis. To be understood as the systemic disease one must say
"<EM>calazar"</EM> or "<EM>leishmaniose
visceral"</EM>. </SPAN></P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN></SPAN> </P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN>Another intriguing spelling is the use of both
<STRONG>leishmaniasis</STRONG> and <STRONG>leishmaniosis, </STRONG>in English
texts. Are there rules for it?</SPAN></P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN></SPAN> </P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN>Cheers,</SPAN></P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN></SPAN> </P></DIV>
<DIV>
<P class=ecxMsoNormal
style="MARGIN-BOTTOM: 12pt"><SPAN>Carlos. </SPAN></P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN>2010/4/8 Christopher Peacock <</SPAN><A
href="mailto:cpeacock@cyllene.uwa.edu.au"><SPAN>cpeacock@cyllene.uwa.edu.au</SPAN></A><SPAN>></SPAN></P>
<DIV>
<DIV>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d">Interesting that the Hindi name (Kala
= black azar = fever) has been taken up and brazlianised so effectively, when
I was in the North East of Brasil researching VL in 1992-94 don’t recall
anyone using the term calazar, they generally called it leishmaniose. It is
also odd that L chagasi doesn’t darken the skin in the same way L. donovani
does so the entire meaning has been lost.</SPAN><SPAN></SPAN>
<P> </P>
<P></P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d"></SPAN><SPAN></SPAN> </P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d">Cheers</SPAN><SPAN></SPAN></P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d"></SPAN><SPAN></SPAN> </P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d">Chris</SPAN><SPAN></SPAN></P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d"></SPAN><SPAN></SPAN> </P>
<DIV
style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0cm; BORDER-TOP: #b5c4df 1pt solid; PADDING-LEFT: 0cm; PADDING-BOTTOM: 0cm; BORDER-LEFT: medium none; PADDING-TOP: 3pt; BORDER-BOTTOM: medium none">
<P class=ecxMsoNormal><STRONG><SPAN
style="FONT-SIZE: 10pt">From:</SPAN></STRONG><SPAN style="FONT-SIZE: 10pt">
Carlos Costa [mailto:<A
href="mailto:chncosta@gmail.com">chncosta@gmail.com</A>]
<BR><STRONG>Sent:</STRONG> Wednesday, 7 April 2010 5:44
PM<BR><STRONG>To:</STRONG> Christopher Peacock<BR><STRONG>Cc:</STRONG> Leish-L
</SPAN></P>
<DIV>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 10pt"><BR><STRONG>Subject:</STRONG> Re: [Leish-l]
name</SPAN></P></DIV></DIV>
<P class=ecxMsoNormal><SPAN></SPAN> </P>
<DIV>
<P class=ecxMsoNormal><SPAN>Interestingly, kala-azar has been adopted plenty
in Brazil as "calazar", since the earlier scientific papers. However, it was
adopted by authors from the Northeast, which is the main endemic area, like
Prata and Alencar. Today, both names are normally use, but one
may feel that visceral leishmaniasis could stand as more educated and
kala-azar (calazar), as more informal, although, in my view both are
interchangeable.</SPAN></P></DIV>
<DIV>
<DIV>
<DIV>
<P class=ecxMsoNormal
style="MARGIN-BOTTOM: 12pt"><SPAN>Carlos.</SPAN></P></DIV>
<DIV>
<P class=ecxMsoNormal><SPAN>2010/4/6 Christopher Peacock <<A
href="mailto:cpeacock@cyllene.uwa.edu.au">cpeacock@cyllene.uwa.edu.au</A>></SPAN></P>
<DIV>
<DIV>
<P class=ecxMsoNormal><SPAN style="FONT-SIZE: 11pt; COLOR: #1f497d">Kala-azar
is the Indian name for visceral leishmaniasis so used extensively in the
Indian sub continent, it literally means black skin in Hindi I believe.
Visceral leishmaniasis is the proper generic name for systemic leishmaniasis
caused by L. donovani, L. infantum and L. (infantum) chagasi. Leishmaniasis
has a vast array of names depending on the type and geographical location,
there was a post on the number of names a few years
ago.</SPAN><SPAN></SPAN></P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d"></SPAN><SPAN></SPAN> </P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d"></SPAN><SPAN></SPAN> </P>
<P class=ecxMsoNormal><SPAN
style="FONT-SIZE: 11pt; COLOR: #1f497d"></SPAN><SPAN></SPAN> </P>
<DIV
style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0cm; BORDER-TOP: #b5c4df 1pt solid; PADDING-LEFT: 0cm; PADDING-BOTTOM: 0cm; BORDER-LEFT: medium none; PADDING-TOP: 3pt; BORDER-BOTTOM: medium none">
<P class=ecxMsoNormal><STRONG><SPAN
style="FONT-SIZE: 10pt">From:</SPAN></STRONG><SPAN style="FONT-SIZE: 10pt"> <A
href="mailto:leish-l-bounces@lineu.icb.usp.br">leish-l-bounces@lineu.icb.usp.br</A>
[mailto:<A
href="mailto:leish-l-bounces@lineu.icb.usp.br">leish-l-bounces@lineu.icb.usp.br</A>]
<STRONG>On Behalf Of </STRONG>Carlos Costa<BR><STRONG>Sent:</STRONG>
Wednesday, 24 March 2010 7:02 AM </SPAN><SPAN></SPAN></P>
<DIV>
<P class=ecxMsoNormal><SPAN style="FONT-SIZE: 10pt"><BR><STRONG>To:</STRONG>
Leish-L<BR><STRONG>Subject:</STRONG> [Leish-l]
name</SPAN><SPAN></SPAN></P></DIV></DIV>
<P class=ecxMsoNormal><SPAN></SPAN> </P>
<DIV>
<P class=ecxMsoNormal><STRONG>Visceral leishmaniasis or kala-azar? Which,
when, how?</STRONG> </P></DIV>
<DIV>
<DIV>
<DIV>
<P class=ecxMsoNormal> </P></DIV>
<DIV>
<P class=ecxMsoNormal style="MARGIN-BOTTOM: 12pt">Carlos.<BR><BR>-- <BR>Carlos
H. N. Costa, MD, DSc.<BR>Instituto de Doenças Tropicais Natan
Portella<BR>Universidade Federal do Piauí<BR>Brazil<BR>Telephone: +55 86
3221-3413</P></DIV></DIV></DIV>
<P class=ecxMsoNormal><BR><SPAN>-- <BR>This message has been scanned for
viruses and <BR>dangerous content by <A
href="http://www.mailscanner.info/"><STRONG>MailScanner</STRONG></A>, and is
<BR>believed to be clean. </SPAN></P>
<DIV class=ecxMsoNormal style="TEXT-ALIGN: center"><SPAN>
<HR SIZE=2>
</SPAN></DIV>
<P class=ecxMsoNormal><SPAN>This e-mail message has been scanned for Viruses
and Content and cleared by <STRONG><SPAN style="COLOR: #400080">MailMarshal
</SPAN></STRONG></SPAN></P>
<DIV class=ecxMsoNormal style="TEXT-ALIGN: center"><SPAN>
<HR SIZE=2>
</SPAN></DIV></DIV></DIV></DIV>
<P class=ecxMsoNormal><BR><BR><BR>-- <BR>Carlos H. N. Costa, MD,
DSc.<BR>Instituto de Doenças Tropicais Natan Portella<BR>Universidade Federal
do Piauí<BR>Brazil<BR>Telephone: +55 86 3221-3413<BR><BR>As informações
contidas nesta mensagem são CONFIDENCIAIS, protegidas pelo sigilo legal, por
direitos autorais e destinadas exclusivamente à pessoa ou organização para a
qual a mensagem foi destinada.<BR><SPAN>Warning: This message is meant only
for the intended recipient of the transmission. It is forbidden any
unauthorized use, alteration, reproduction and distribution. If you are not
the correct recipient, please notify us immediately by return e-mail and
delete this message from your system.
</SPAN></P></DIV></DIV></DIV></DIV></DIV>
<P class=ecxMsoNormal><SPAN><BR><BR><BR></SPAN>-- <BR>Carlos H. N. Costa, MD,
DSc.<BR>Instituto de Doenças Tropicais Natan Portella<BR>Universidade Federal
do Piauí<BR>Brazil<BR>Telephone: +55 86 3221-3413<BR><BR>As informações
contidas nesta mensagem são CONFIDENCIAIS, protegidas pelo sigilo legal, por
direitos autorais e destinadas exclusivamente à pessoa ou organização para a
qual a mensagem foi destinada.<BR><SPAN>Warning: This message is meant only
for the intended recipient of the transmission. It is forbidden any
unauthorized use, alteration, reproduction and distribution. If you are not
the correct recipient, please notify us immediately by return e-mail and
delete this message from your system. </SPAN></P></DIV>
<P>
<HR>
<P></P>_______________________________________________<BR>Leish-l mailing
list<BR>Leish-l@lineu.icb.usp.br<BR>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<BR></BLOCKQUOTE></BODY></HTML>